On June 10, 2025, PetMeds announced that it needed to delay the release of its 2025 fourth quarter and year-end financial results. on July 1, 2025, it revealed a further delay in the filing of its financial results, in part, because of an internal investigation into revenue recognition. On August 12, 2025, PetMeds' CEO and CFO resigned, and the Company's stock price has fallen by almost 30% on this news.
Contact our attorneys for a no-cost case evaluation.